DE:9TD Stock Latest News
Company AnnouncementsArctic Bioscience Reports 26% Year-to-Date Revenue Growth in Q3 20261w ago9TD
Company AnnouncementsArctic Bioscience Sets Date for Third-Quarter Update2w ago9TD
Company AnnouncementsArctic Bioscience Plans CFO Transition as Company Seeks Successor1M ago9TD
Company AnnouncementsArctic Bioscience Delivers Strong H1 Sales Growth and Advances Psoriasis Drug Candidate2M ago9TD
Company AnnouncementsArctic Bioscience Sets Date for H1 2026 Results and Investor Webcast3M ago9TD
Company AnnouncementsArctic Bioscience Posts New Psoriasis Inflammation Data Backing Herring Roe Oil Drug3M ago9TD- Company AnnouncementsArctic Bioscience psoriasis drug shows biomarker-driven benefit in phase 2b trial6M ago9TD
- Company AnnouncementsArctic Bioscience Publishes 2025 Annual Report After Board Approval6M ago9TD
Company AnnouncementsArctic Bioscience Posts Record Q1 on U.S.-Led Growth and Secures New Financing6M ago9TD
Company AnnouncementsArctic Bioscience Sets Date for Q1 2026 Operational Update and Webcast7M ago9TD
Company AnnouncementsArctic Bioscience Board-Linked Shareholders Back New Long-Term Financing7M ago9TDCompany AnnouncementsArctic Bioscience Cuts Costs and Builds Pipeline as Nutraceutical Growth Rebounds After Recall8M ago9TD
Company AnnouncementsArctic Bioscience Sets Date for Q4 2025 Operational Update and Webcast8M ago9TD
Company AnnouncementsArctic Bioscience to Present Glaucoma Drug Candidate ABS403 at Glaucoma 360 Forum9M ago9TD
Company AnnouncementsArctic Bioscience Expands Share Capital to Reinforce Operations11M ago9TD
Company AnnouncementsArctic Bioscience Boosts Share Capital Through Debt Conversion11M ago9TD
Company AnnouncementsArctic Bioscience Investor Converts Debt to Equity11M ago9TDCompany AnnouncementsArctic Bioscience Reports Promising Q3 2025 Results and Strategic Advancements1y ago9TD

